Healthcare Magazine February 2018 | Page 31

The estimated value of the global market for diabetes devices in 2024
The estimated value of the overall market for diabetes diagnostics in 2017
71 % The percentage of teststrips accounted for of the total market in 2015
A German company with global potential DiaMonTech prides itself that all of its technology and devices have so far been completed with German DNA : German engineers have been responsible for the transformation from a research project to a medical project .
“ We have one engineering partner , Seleon , who supports us with their knowledge in making medical products ready for mass production , and with their expertise in all regulatory affairs ,” explains Mäntele . “ We outsourced the building of the devices , plus CE and medical device certification . It ’ s a regulatory challenge to get the CE approval and to optimise the medical device . At DiaMonTech we focus on research and development of a prototype .”
Apple , with its spectacular global reach , has been battling it out to delve into molecular spectroscopy technology , which begs the question of whether DiaMonTech would consider any kind of collaboration with the tech giant , or indeed any other organisation of similar size . Even a business the size of Apple would not hold any advantage in terms of the

$ 35.5 BILLION

The estimated value of the global market for diabetes devices in 2024

$ 157 BILLION

The estimated value of the overall market for diabetes diagnostics in 2017

71 % The percentage of teststrips accounted for of the total market in 2015

“ Non-invasive glucose measuring has become more of a holy grail within the market for diabetic products in recent years ”

Professor Werner Mäntele
31